The {pharmaceutical industry is increasingly exploring novel treatment strategies for obesity , and the introduction of semaglutide 10mg injectables represents a significant change. Healthcare providers are cautiously consider the possible benefits and challenges associated with this increased potency product, particularly in relation to existing s